Specialty Pharmacy

04/08/2013 - 1:35pm

Patients taking AstraZeneca RA drug show partial improvement

An experimental drug developed by AstraZeneca for rheumatoid arthritis produced mixed results in measurements of patients' conditions, according to results of a late-stage clinical trial.

04/08/2013 - 12:20pm

Specialty pharmacy conference brings together industry experts

A joint conference by the National Association of Specialty Pharmacy and the Association of Managed Care Pharmacy attracted hundreds of leaders from across the specialty pharmacy industry.

04/08/2013 - 10:43am

BioPlus adds 2-hour guarantee to patient referrals

BioPlus Specialty Pharmacy will notify physicians within two hours whether a patient has been accepted for treatment, the company said.

04/08/2013 - 10:35am

Teva introduces generic painkiller

Teva Pharmaceutical Industries has launched a generic opioid medication for treating pain, the company said.

04/05/2013 - 1:06pm

GSK tests lupus drug in patients with inflammatory blood vessel disorder

GlaxoSmithKline has started a late-stage clinical trial of a drug in patients with an inflammatory disease that affects the blood vessels.

04/04/2013 - 5:18pm

Covis buys rights to five drugs from Sanofi

Swiss drug maker Covis Pharma will buy U.S. rights to five drugs from Sanofi, Covis said.

04/04/2013 - 3:33pm

Reports: Novartis launches new ad campaign aimed at young adults

Novartis is promoting the multiple sclerosis drug Gilenya to young people with a new ad campaign in several national magazine's and websites, according to published reports.

04/04/2013 - 2:57pm

Florida Senate committee passes biosimilar bill

A committee of Florida's state Senate has passed a bill that could limit the use of biosimilars in the state.

04/04/2013 - 2:09pm

FDA grants tentative approval to Aurobindo HIV drug

The Food and Drug Administration has given preliminary approval to a drug made by Aurobindo Pharma for treating HIV infection, the drug maker said.

04/04/2013 - 1:42pm

URAC gives accreditation to PBM-owned specialty pharmacy

Washington-based accrediting organization URAC has accredited pharmacy benefit manager Catamaran Corp.'s specialty pharmacy brand, Catamaran said.